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ABSTRAK
Penyakit kanser sel basal (KSB) di bahagian skrotum jarang ditemui dan punca ia 
berlaku tidak difahami dengan baik. KSB yang tumbuh di skrotum ini dikatakan 
lebih agresif dan mempunyai kebolehan merebak yang lebih tinggi daripada KSB 
kawasan-kawasan lain. Rawatan utama untuk KSB peringkat awal di skrotum 
adalah pembedahan, manakala untuk peringkat lanjut di mana penyakit telah 
merebak, ia perlu dikawal dengan rawatan kemoterapi. Satu keadaan klinikal 
yang luar biasa di mana KSB skrotum berlaku serentak dengan kanser yang lain 
tidak pernah dilaporkan. Kes ini mengisahkan cabaran diagnostik dan rawatan 
kerana KSB skrotum dan kanser sel squamous (KSS) berlaku pada waktu yang 
sama. Seorang lelaki berusia 70 tahun mengadu wujudnya ulser di skrotum beliau 
yang tidak sembuh selama lebih setahun. Pada ketika itu, beliau sedang disiasat 
kerana mengalami penyakit KSS di telinga yang berada di peringkat lanjut. Ulser 
di skrotum itu pada mulanya dianggap sebagai KSS yang telah merebak ke situ. Ia 
kemudiannya didapati penyakit KSB dengan biopsi dan pemeriksaan histopatologi. 
Beliau menjalani pembedahan untuk membuang ulser di skrotum dan diikuti dengan 
kemoterapi paliatif menggunakan cisplatin dan radioterapi ke atas kumpulan-
kumpulan limpa yang dijangkiti KSS. Enam bulan selepas tamatnya rawatan paliatif, 
beliau kekal sihat dan tidak mempunyai apa-apa kesan KSB berulang di skrotum. 
Rawatan pembedahan bersama dengan kemoterapi dan radioterapi paliatif dapat 
memberi kualiti hidup yang baik untuk pesakit yang ditimpa KSB skrotum dan KSS 
peringkat lanjut.
Kata kunci: kanser sel basal, kanser cell squamous, skrotum
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ABSTRACT
Basal cell carcinoma (BCC) of the scrotum is uncommon and its pathogenesis is 
not well understood. The clinical behaviour of scrotal BCC is thought to be more 
aggressive and has a higher metastatic potential than BCC of other regions. The 
mainstay of treatment for localized scrotal BCC is wide local excision, while 
metastatic disease may need systemic chemotherapy for palliative control. A rare 
clinical scenario of scrotal BCC presenting concurrently with another metastatic 
cancer has never been reported. The present case illustrates the diagnostic challenge 
and management dilemma due to simultaneous presentation of scrotal BCC and 
metastatic squamous cell carcinoma (SCC). A 70-year-old man complained of a 
non-healing scrotal ulcer while he was being investigated for metastatic squamous 
cell carcinoma (SCC) of the external auditory meatus. The scrotal lesion was 
initially thought to be metastatic SCC. It was later confirmed to be BCC with 
biopsy and histopathological examination. He underwent surgical resection of the 
scrotal BCC for local control followed by palliative chemotherapy with cisplatin 
and radiotherapy for lymph node metastases. He remained well and did not have 
any local recurrence following 6 months after palliative treatment. Surgery coupled 
with palliative chemoradiation can offer good quality of life for patients with scrotal 
BCC and concurrent metastatic SCC.
Keywords: basal cell carcinoma, squamous cell carcinoma, scrotum
(Cieplinski 1984; Jeon et al. 2006). To 
our knowledge, scrotal BCC occurring 
concurrently with another metastatic 
carcinoma has never been reported. 
We encountered a rare case of scrotal 
BCC in the presence of metastatic 
squamous cell carcinoma (SCC) of 
the ear canal. This case illustrates the 
challenges encountered in diagnosing 
and treatment. It also highlights a 
palliative strategy that provides the 
patient with a good quality of life.
CASE REPORT
A 70-year-old male complained of 
having a chronic and non-healing 
ulcer on his left hemiscrotum for two 
yrs. He used to work as a supervisor 
at a chemical factory for over 20 
INTRODUCTION
Basal cell carcinoma (BCC) is a skin 
malignancy that commonly affects sun-
exposed areas of the body such as the 
head and neck region (Jeon et al. 2006; 
Wang et al. 2010). However, BCC of 
the scrotum quite uncommon (Dai et 
al. 2012; Jeon et al. 2006; Kinoshita et 
al. 2005) and its pathogenesis is not 
well understood (Jeon et al. 2006). It 
is thought to be more aggressive and 
metastasizes earlier than BCC of other 
parts of the body (Kinoshita et al. 
2005). Localized scrotal BCC is usually 
treated with wide local excision (Delto 
et al. 2016; Jeon et al. 2006; Ribuffo 
et al. 2002; Wang et al. 2010) but 
metastatic disease may require systemic 
chemotherapy for disease control 
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yrs. The job involved exposure and 
close contact with various chemicals 
including magnesium sulphate, nitric 
oxide, ammonia, paraquat, liquid 
hydrogen, chlorine gas and sulphur 
compounds. The scrotal lesion was 
made known to us while he was 
undergoing investigation for SCC of his 
right external auditory meatus. The SCC 
was found to have metastasized to the 
liver and lymph nodes in the abdomen 
and pelvis. The concomitant presence 
of this metastatic SCC raised the 
suspicion that the scrotal lesion could 
be a metastatic secondary. On physical 
examination, the lesion was located 
at the inferior part of the scrotum. It 
measured 3cm x 4cm in size, and had 
pearly irregular borders and central 
ulceration (Figure 1). It had a hard 
consistency but it did not feel adherent 
to the underlying tunica vaginalis and 
testes. The clinical appearance of this 
scrotal lesion was uncharacteristic of 
SCC. His inguinal lymph nodes were 
also found to be enlarged bilaterally. 
A wedge biopsy of the scrotal lesion 
unexpectedly diagnosed it to be BCC 
instead of metastatic SCC (Figure 2).
 He underwent wide local excision 
(WLE) of the scrotal lesion with the 
intention for local disease control. 
Intraoperatively, the tumour was 
resected with at least 1 cm macroscopic 
margin. However, the histopathological 
examination (HPE) showed nodular, 
infiltrative pattern BCC of the scrotum 
with inadequate resection margin. 
Meanwhile, he developed a new 
satellite scrotal sinus just near the base 
of penis. He subsequently underwent 
further excision of the scrotal scar 
and sinus. While the scrotal scar HPE 
showed good clearance margin this 
time, the scrotal sinus was found 
to harbour even more BCC. After 
surgery, he was treated with palliative 
chemoradiation consisting of 6 cycles 
of cisplatin 30mg/m2, and 70 Gy in 
35 fractions of radiotherapy to the 
metastatic neck and abdominal lymph 
nodes. He remained well six months 
Figure 1: Scrotal lesion measuring 3cm x 4cm 
over the inferior part of the scrotum. It had 
pearly irregular borders and a central ulceration.
Figure 2: Histological features of basal cell 
carcinoma seen under microscopic examination 
(x200). It showed tissue made up of islands of 
closely packed malignant cells, palisaded outer 
row of cells and mucinous material surrounding 
the malignant cells. There were numerous 
mitotic figures and the stroma was infiltrated by 
lymphocytes and plasma cells.
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after completing palliative treatment 
and there was no local recurrence of 
the scrotal BCC.
DISCUSSION
Basal cell carcinoma is the commonest 
skin cancer in most parts of the world 
(Lomas et al. 2012). It is widely accepted 
that excessive exposure to ultraviolet 
(UV) radiation is a major risk factor for 
developing BCC (Wang et al. 2010). 
Therefore, most BCC occur on parts 
of the skin that are usually exposed 
to sun (Jeon et al. 2006), and BCC of 
the scrotum is understandably quite 
uncommon (Dai et al. 2012; Jeon et 
al. 2006; Kinoshita et al. 2005). Unlike 
SCC of the scrotum that has several 
established risk factors, scrotal BCC 
does not have any clear relations with 
carcinogen exposure. (Jeon et al. 2006). 
Indeed, its pathogenesis still remains 
unclear and few postulations were 
proposed. These include impaired 
immune surveillance, genetic mutation 
and even chronic irritation (Jeon et al. 
2006; Ouchi & Sugiura 2008; Wang et 
al. 2010). 
 Scrotal BCC is also thought to 
behave more aggressively than its 
counterpart located elsewhere on the 
body. Metastatic scrotal BCC is known 
to occur much earlier, at around 2-3 yrs 
after the initial diagnosis; in contrast, 
BCC on other sites that metastasize at 
an average time of 11 yrs after being 
diagnosed (Kinoshita et al. 2005). 
The commonest sites of metastasis 
are lymph nodes, lungs and bones 
(Kinoshita et al. 2005). Nevertheless, 
there was a single case report of scrotal 
BCC that remained dormant for over 50 
yrs (Wang et al. 2010). Unfortunately, 
we were unable to predict which 
patient would have metastasis sooner 
than others. Previous attempts at 
using histological features to predict 
metastatic potential have been largely 
unsuccessful (Kinoshita et al. 2005). 
Therefore, we must remain vigilant for 
the possibility of early distant spread in 
all cases of scrotal BCC.
 The present case was a diagnostic 
challenge to us because while the patient 
was being investigated for metastatic 
SCC of the external auditory meatus, he 
alerted us about an ulcerating lesion on 
his scrotum. The initial impression was 
that the scrotal lesion should also be 
squamous cell in origin and treatment 
would follow the course for SCC. 
However, a biopsy of the lesion found it 
to be BCC. This then posed a question 
of whether to wide local excision of the 
scrotal was appropriate in the presence 
of widespread metastatic SCC from 
his ear. Furthermore, we also faced 
a dilemma in deciding the systematic 
therapy that he should receive in this 
unusual situation.
 Most authors agree that surgery is 
the mainstay of treatment for localized 
scrotal BCC (Delto et al. 2016; Jeon et 
al. 2006; Ribuffo et al. 2002; Wang et 
al. 2010). A clear surgical margin of > 6 
mm reduces the risk of disease relapse 
(Delto et al. 2016). Other authors 
advocate greater clear surgical margin 
of 2-3cm for complete resection of the 
local disease (Hernández-Aragüés & 
Baniandrés-Rodríguez 2016). In cases 
where metastases occurred, systemic 
chemotherapy should be administered 
(Cieplinski 1984; Jeon et al. 2006) and 
a cisplatin-based combination seems to 
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produce acceptable results (Cieplinski 
1984). Of particular note, metastatic 
scrotal SCC can also be treated 
with cisplatin in combination with 
methotrexate and bleomycin (Vyas et 
al. 2014). 
 We offered the patient wide local 
excision of his scrotal BCC as a means for 
local control and also to free him from 
the constant discomfort of an ulcerating 
lesion. This was followed by palliative 
systemic treatment with cisplatin 
chemotherapy, and radiotherapy to the 
metastatic lymph nodes at his neck and 
abdomen. This treatment strategy gave 
him a good quality of life at 6 months, 
post-chemoradiation. 
CONCLUSION
In conclusion, a patient with scrotal 
BCC presenting concurrently with 
metastatic SCC of the ear is rare and 
can be a challenge to manage. A careful 
and individualized treatment plan, 
combining surgery, chemotherapy and 
radiotherapy can provide excellent 
palliative outcome in this clinical 
scenario. 
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